STARTUP PROFILE

TheraSonic

COUNTRY
France
FOUNDED
2023
CATEGORY
Tools and Infrastructure
Developing transcranial focused ultrasound systems to transiently open the blood-brain barrier for targeted CNS drug delivery.
Visit website →
Neurofounders Insights
$   Funding   -
Pre-seed
MODALITY
Ultrasound
FORM FACTOR
Surgical system
INTERFACE DEPTH
Non-invasive
INDICATION
Other
TARGET USER
Pharma
REGULATORY STAGE
Preclinical
TheraSonic is best understood as an enabling platform for CNS therapeutics, using focused ultrasound, robotics, and neuronavigation to address brain drug delivery. Its position sits before clinical validation, with brain metastases as the clearest initial use case and broader neurological applications remaining translational.
Mentioned in Market Notes
MOST RECENT COVERAGE
No items found.
Articles featuring
TheraSonic
No items found.